Monday, September 23, 2019

Versant Ventures Portfolio Firm Nears IPO

A portfolio company of San Diego-based biopharmaceuticals venture investor Versant Ventures is getting set for its IPO this week. Aprea Therapeutics said that estimates its IPO will price between $14.00 and $16.00 per share, which could raise as much as $92.0M for the biotech. Aprea--based in Boston and Sweden--says it has applied to lis

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.